Novo Nordisk A/S (NVO) CEO Lars Jørgensen on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/01/19
How This Pharma Stock Could Knock Eli Lilly Off Its Diabetes PedestalInvestors Business Daily • 09/17/19
5 High-Quality Dividend Contenders From Overseas To Diversify Your Dividend Growth PortfolioSeeking Alpha • 09/13/19
Pharma Stocks Hammered As House Proposal Aims To Slash Drug PricesInvestors Business Daily • 09/10/19